Latest filing published 17 Dec 2021 for Organogenesis Holdings Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dennis Erani: trading record in brief
Dennis Erani is a declared insider of Organogenesis Holdings Inc. (chief executive), with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 27 May 2021 and the latest from 15 December 2021.
Every open-market trade on record is a sale: 1 sale worth €142k.
Most recently, on 17 December 2021, the filings show a transaction in Organogenesis Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dennis Erani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,417,900 shares0Class A Common StockSEC:0001062993-21-013189:0
- 9,106 shares@ US$18.97100.0% of flowClass A Common StockSEC:0001661181-21-000060:0
2 of 2 declarations
